Latest post

Oxurion NV Partners with Prevent Blindness to Educate Public on Diabetes-related Eye Disease

Both Oxurion and Prevent Blindness join forces during November to educate the public on risk factors, symptoms, treatment options, and financial assistance resources.

science community

Perspectives 2019 available for download

Oxurion’s Perspectives Magazine 2019 is here! Discover last year’s highlights and a glimpse of what's ahead in 2019 in the latest issue of our annual magazine.

back of the eye diseases, science community

Research opportunities for treating age-related macular degeneration

Age-related macular degeneration (or AMD) is the leading cause of blindness. At Oxurion, we’re discovering new ways to treat both forms.

back of the eye diseases, eye community

3 reasons why we need to raise diabetic eye disease awareness

Diabetic eye diseases affect millions of people globally, and still there's a high unmet need in diagnosis and treatment. It's high time to get the message across to risk groups.

back of the eye diseases

9 striking facts about diabetic eye disease

In this post, we’ll share some striking facts and numbers about diabetes and diabetic eye disease.

back of the eye diseases, eye community

Sehnaz Karadeniz on tackling diabetes and related vision problems

Diabetic eye disease is currently one of the leading causes of preventable blindness in the working population worldwide. Early treatment and diagnosis is crucial for prevention.

back of the eye diseases, eye community

Creating Diabetic Eye Disease Awareness with Prevent Blindness

This November, in support of Diabetic Eye Disease Awareness Month, Oxurion is partnering with Prevent Blindness and its sight saving efforts.

science community

“An aspiring name to reflect our focus and ambition”

“The new name comes from combining the words Oxygen and Orion”, explains CEO Patrik De Haes, MD. “Raising oxygen levels in cells plays a key role in helping prevent and reverse ...

eye community

“Cutting-edge research can change people’s lives”

“Partnerships with the industry and biotech companies like Oxurion are crucial to us,” says Jeff Todd, President & CEO of Prevent Blindness US. “It is vital that ...

back of the eye diseases, science community

“We need therapies fighting different hallmarks simultaneously”

PDR and DME are two manifestations of diabetic retinopathy (DR), and in many respects they stem from the same cause, explains Prof. Alan Stitt, Dean of Innovation & Impact and ...

eye community

“Join forces to fight eye disease in developing countries”

“In those parts of the world there are many patients who lack access to routine retinal care,” Dr. Agrawal explains. “We aim to provide clinical care by sending retina ...

oncology research

“Looking at the future of immuno-oncology therapy”

This past year Oncurious concluded an agreement with VIB to acquire exclusive licenses to a portfolio of five innovative immuno-oncology assets. Those unique new targets ...

eye community

“Training ophthalmologists to fight blindness in developing countries”

“Our key ambition is to put an end to avoidable blindness worldwide,” says Isabelle Verhaegen, Director of Light for the World. “Creating awareness of eye diseases really is ...